Literature DB >> 93780

Prostatism. I. The correlation between symptoms, cystometric and urodynamic findings.

J T Andersen, J Nordling, S Walter.   

Abstract

One hundred and seven consecutive patients referred with symptoms of bladder outlet obstruction were studied using cystometry and combined pressure-flow-electromyographic investigation. The symptoms of infravesical obstruction were not statistically significantly correlated to the hydrodynamic documentation of increased bladder outlet resistance as judged by maximum flow rate and the calculated urethral resistance. Irritative symptoms such as frequency, nocturia, urgency and urgeincontinence were statistically significantly correlated to the presence of detrusor hyperreflexia. The functional disorder bladder neck dyssynergia was encounterd in 5% of the patients (95% confidence limits 1-10%). This diagnosis cannot be made by conventional urological investigations. It is concluded that objective demonstration of infravesical obstruction is mandatory in the selection of patients with symptoms of lower urinary tract dysfunction for surgery on the prostate or the bladder neck.

Entities:  

Mesh:

Year:  1979        PMID: 93780     DOI: 10.3109/00365597909179530

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  14 in total

Review 1.  Benign prostatic hyperplasia and its treatment.

Authors:  J B Stimson; S D Fihn
Journal:  J Gen Intern Med       Date:  1990 Mar-Apr       Impact factor: 5.128

2.  The significance of age on symptoms and urodynamic- and cystoscopic findings in benign prostatic hypertrophy.

Authors:  O Simonsen; B Møller-Madsen; T Dørflinger; J P Nørgåard; H S Jørgensen; E Lundhus
Journal:  Urol Res       Date:  1987

3.  Imaging of the urinary tract.

Authors:  M A Stott; P H Abrams; F C Feneley
Journal:  Br Med J (Clin Res Ed)       Date:  1988-05-21

Review 4.  Benign prostatic hyperplasia.

Authors:  R J Simpson
Journal:  Br J Gen Pract       Date:  1997-04       Impact factor: 5.386

5.  Symptomatic and urodynamic evaluation of patients undergoing prostatectomy.

Authors:  M K O'Donohoe; J M Fitzpatrick; J M Smith
Journal:  Ir J Med Sci       Date:  1988-08       Impact factor: 1.568

Review 6.  Benign prostatic hyperplasia. Practical treatment guidelines.

Authors:  T Tammela
Journal:  Drugs Aging       Date:  1997-05       Impact factor: 3.923

7.  Urinary symptoms: prevalence and severity in British men aged 55 and over.

Authors:  D J Hunter; C M McKee; N A Black; C F Sanderson
Journal:  J Epidemiol Community Health       Date:  1994-12       Impact factor: 3.710

8.  Disturbances of bladder and urethral function in Parkinson's disease.

Authors:  J T Andersen
Journal:  Int Urol Nephrol       Date:  1985       Impact factor: 2.370

Review 9.  Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia.

Authors:  M I Wilde; A Fitton; E M Sorkin
Journal:  Drugs Aging       Date:  1993 May-Jun       Impact factor: 3.923

Review 10.  Alfuzosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia.

Authors:  M I Wilde; A Fitton; D McTavish
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.